OKLAHOMA CCOP

俄克拉荷马州 CCOP

• 批准号: 6512409
• 负责人: James B Lockhart
• 金额: $ 53.6万
• 依托单位: WARREN CANCER RESEARCH FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-08-13 至 2003-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6512409
• 关键词: breast neoplasm /cancer diagnosis; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; clinical research; clinical trials; community health services; continuing education; cooperative study; data management; early diagnosis; health services research tag; human subject; human therapy evaluation; mammography; mass screening; medical outreach /case finding; medical rehabilitation related tag; neoplasm /cancer; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer therapy; primary care physician; prostate neoplasms; smoking cessation; tobacco abuse education

The Oklahoma Community Clinical Oncology Program (CCOP) is applying as a consortium consisting of 1) Saint Francis Hospital and the Natalie Warren Bryant Cancer Center (NWBCC); 2) Cancer Care Associates (CCA), the core investigators responsible for cancer program development at Saint Francis for over twenty years; and 3) Warren Cancer Research Foundation (WCRF). This cancer program is currently in year eleven as a funded CCOP, previously known as the Saint Francis/NWBCC CCOP. The Warren Cancer Research Foundation serves as the administrative body for the cancer research program and will serve as the grantee and fiscal agent for the Oklahoma CCOP. The projected year 11 accrual is 80 patients on treatment protocols and 60 credits on cancer prevention and cancer control studies. Saint Francis Hospital is a 650 bed non-profit teaching hospital serving over 1.5 million residents of Eastern Oklahoma as well as 1.9 million residents in adjacent portions of Kansas, Missouri, and Arkansas. The Oklahoma CCOP Consortium is the only CCOP in the state and is the largest provider of cancer care in the area, capturing 66.9 percent of the healthcare market in Eastern Oklahoma. Total cancer patient accession is projected to be 2,400 patients and 28,500 visits for 1998. The CCOP Investigators have had a long-standing relationship with ECOG (since 1976) and established formal affiliations with M.D. Anderson and NSABP in 1986 and 1988, respectively. An additional affiliation was established with GOG in August, 1997. These research bases offer a variety of excellent treatment trials as well as promising cancer prevention and control studies in which the CCOP plans to participate. The CCOP has defined its immediate objectives as: increasing accrual in clinical trials and prevention/cancer control studies; increasing the range of healthcare providers participating in clinical trials; and increasing public awareness of NCI-approved clinical research to improve acceptance and endorsement of these efforts.

俄克拉荷马州社区临床肿瘤学计划（CCOP）应用于 一个由1）圣弗朗西斯医院和纳塔利组成的财团 沃伦·布莱恩特癌症中心（NWBCC）； 2）癌症护理伙伴（CCA）， 负责癌症计划开发的核心调查人员 圣弗朗西斯超过二十年； 3）沃伦癌研究 基金会（WCRF）。 该癌症计划目前在十一年级 资金的CCOP，以前称为圣弗朗西斯/NWBCC CCOP。 这 沃伦癌症研究基金会是 癌症研究计划，并将作为受赠人和财政 俄克拉荷马州CCOP的代理商。 预计的11年应计为80 治疗方案的患者和60个预防癌症和60个学分 癌症控制研究。 圣弗朗西斯医院是一家650张床的非营利教学医院服务 俄克拉荷马州东部的150万居民和190万 堪萨斯州，密苏里州和阿肯色州附近的居民。 这 俄克拉荷马州CCOP联盟是该州唯一的CCOP，是 该地区最大的癌症护理提供商，捕获66.9％ 俄克拉荷马州东部的医疗市场。 总癌症患者 预计1998年的加入为2,400名患者和28,500次就诊。 CCOP调查人员与ECOG有着长期的关系 （自1976年以来）并建立了与M.D. Anderson和 NSABP分别于1986年和1988年。 另一个隶属关系是 1997年8月与GOG成立。这些研究基础提供了 各种优秀的治疗试验以及有希望的癌症 CCOP计划参加的预防和控制研究。 CCOP将其直接目标定义为：增加应计 临床试验和预防/癌症控制研究；增加 参加临床试验的医疗保健提供者范围；和 提高公众对NCI批准的临床研究的认识以改善 接受和认可这些努力。